References
- Hertervig E, Wieslander J, Johansson C, Wiik A, Nilsson A. Antineutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Scand J Gastroenterol 1995; 30: 693–8
- Stoffel M P, Csernok E, Herzberg C, Johnston T, Carroll S F, Gross W L. Antineutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Clin Exp Immunol 1996; 104: 54–9
- Zhao M H, Jones S J, Lockwood C M. Bactericidal/permeability increasing protein (BPI) is an important antigen for anti‐neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 1995; 99: 49–56
- Gross W L, Csernok E. Immunoadiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol 1995; 7: 11–9